192139-92-7
Produktnavn: Chloro{[(1R,2R)-(-)-2-amino-1,2-diphenylethyl](4-toluensulfonyl)amido}(p-cymen)ruthenium (II)
CAS192139-92-7
MF:C21H21ClN2O2RuS.C10H14
MW: 636,219
EINECS:
MDL-nr.: MFCD10567385
Send forespørgsel
Beskrivelse
Specifikation:
| Udseende | Orangebrunt pulver |
| Renhed | 98%,Ru>15.7% |
Anvendelse:
Chlor{[(1R,2R)-(-)-2-amino-1,2-diphenylethyl](4-toluensulfonyl)amido}(p-cymen)ruthenium(II) har vigtige anvendelser i homogene katalytiske reaktioner. Det kan bruges til at katalysere forskellige organiske reaktioner, herunder hydrogenering, oxidation, olefinisotopudveksling osv. Det kan også bruges til hydrogenoverførsel og selektive oxidationsreaktioner i organisk syntese.
Synonymer:
| RuCl(p-cymen)[(R,R)-Ts-DPEN] (1R,2R)-2-amino-1,2-diphenylethyl]-(4-methylphenyl)sulfonylazanid ((R,R)-2-AMINO-1,2-DIPHENYLETHYL)[(4-TOLYL)SULFONYL]AMIDO](P-CYMEN)RUTHENIUM(II)CHLORID ((R,R)-2-amino-1,2-diphenylethyl)[(4-tolyl)sulfonyl]amido](p-cymen)ruthenium(ii)chlorid Chlor{[(1R,2R)-(-)-2-amino-1,2-diphenylethyl](4-toluensulfonyl)amido}(p-cymen)ruthenium(II) |
Relaterede produkter:
| Chlor(2-dicyclohexylphosphino-2',4',6'-triisopropyl-1,1'-biphenyl)[2-(2'-amino-1, 1'-biphenyl)]palladium(II) | 1310584-14-5 |
| Chlor(2-dicyclohexylphosphino-2',6'-diisopropoxy-1,1'-biphenyl)[2-(2'-amino-1,1'- biphenyl)]palladium(II) | 1375325-68-0 |
| Chlor(2-dicyclohexylphosphino-1,1-biphenyl)[2-(2-amino-1,1-biphenyl)]palladium( II) | 2230788-61-9 |
| Chlor[4-(di-tert-butylphosphino)-N,N-dimethylanilin-2-(2'-aminobiphenyl)]palladium(II) | 2169976-34-3 |
| Chlor[(tri-tert-butylphosphin)-2-(2-aminobiphenyl)] palladium(II) | 1375325-71-5 |
| Chlor[(tricyclohexylphosphin)-2-(2'-aminobiphenyl)]palladium(II) | 1353658-81-7 |
| Chlor[(4,5-bis(diphenylphosphino)-9,9-dimethylxanthen)-2-(2-amino-1,{{7} }biphenyl)]palladium(II) | 1375325-77-1 |
| Chlor[(di(1-adamantyl)-N-butylphosphin)-2-(2-aminobiphenyl)]palladium(II) | 1375477-29-4 |
Populære tags: 192139-92-7, Kina 192139-92-7 producenter, leverandører
Et par af: 192139-90-5
Næste: 130004-33-0
Inquiry
